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Abstract 30 
Chlamydia psittaci and Chlamydia abortus are closely related intracellular bacteria exhibiting different 31 
tissue tropism that may cause severe but distinct infection in humans. C. psittaci causes psittacosis, a 32 
respiratory zoonotic infection transmitted by birds.  C. abortus is an abortigenic agent in small ruminants, 33 
which can also colonize the human placenta and lead to foetal death and miscarriage. Infections caused by 34 
C. psittaci and C. abortus are underestimated mainly due to diagnosis difficulties resulting from their strict 35 
intracellular growth. We developed a duplex real-time PCR to detect and distinguish these two bacteria in 36 
clinical samples. The first PCR (PCR1) targets a sequence of the 16S-23S rRNA operon allowing the 37 
detection of both C. psittaci and C. abortus. The second PCR (PCR2) targets the coding DNA sequence 38 
CPSIT_0607 unique to C. psittaci. The two PCR showed 100% detection for 10 or more DNA copies per 39 
reaction (1000 copies per ml). Using a set of 120 samples including bacterial reference strains, clinical 40 
specimens and infected cell culture material, we monitored 100% sensitivity and 100% specificity for the 41 
detection of C. psittaci and C. abortus for PCR1. When PCR1 was positive, PCR2 could discriminate C. 42 
psittaci from C. abortus with a positive predictive value of 100% and a negative predictive value of 88%. 43 
In conclusion, this new duplex PCR represents a low cost and time saving method with high throughput 44 
potential, expected to improve the routine diagnosis of psittacosis and pregnancy complication in large-45 
scale screening programs and also during outbreaks.  46 
  47 
Introduction 48 
Chlamydia psittaci and Chlamydia abortus belong to the family Chlamydiaceae that comprises obligate 49 
intracellular bacteria. This family includes pathogenic members with specific host and tissue tropism 50 
responsible for a broad range of diseases both in humans and animals (Corsaro & Greub 2006) (Baud et al. 51 
2011) (Asner et al. 2014). C. psittaci is responsible worldwide for respiratory tract infections ranging from 52 
benign illness to severe pneumoniae with fatal outcomes. The primary reservoir of C. psittaci is birds, in 53 
particular parrots and parakeets (Longbottom & Coulter 2003) but recent studies on chicken from the food 54 
industries and on feral pigeons suggest a significant prevalence of C. psittaci in these animals as well 55 
(Magnino et al. 2009; Geigenfeind et al. 2012; Yin et al. 2013). Transmission between birds is primarily 56 
achieved through the inhalation of aerosols containing desiccated infectious particles originating from 57 
contaminated birds faeces. Infected birds can be asymptomatic hosts or develop respiratory tract disease, 58 
namely ornithosis (Longbottom & Coulter 2003). The transmission from birds to humans can be achieved 59 
through close interaction with infected birds or by inhalation of infected particles present in bird faeces 60 
(Haag-Wackernagel & Moch 2004). The clinical expression of human psittacosis ranges from flu-like 61 
illness to an atypical severe pneumonia (Longbottom & Coulter 2003). C. abortus can invade the placenta 62 
and lead to abortions or foetal death in the late stage of pregnancy, especially in ruminants. In sheep, C. 63 
abortus-induced disease is known as Ovine Enzootic Abortion (OEA), which is one of the principal causes 64 
of lamb loss worldwide (Longbottom & Coulter 2003). C. abortus can also infect other mammals such as 65 
goats, cattle, pigs, horses and deer with the same outcomes and can also be transmitted to humans through 66 
contact with infected animal placentas that may contain a large quantity of infectious C. abortus organisms. 67 
C. abortus infection is generally asymptomatic in non-pregnant animals but can colonize the placenta of 68 
pregnant mammals, where it causes destruction of the placental tissue ultimately resulting in foetal death 69 
and late-term abortion or miscarriage. 70 
Both C. psittaci and C. abortus infections require rapid and accurate diagnosis in order to effectively 71 
manage infected animals and humans and to limit or prevent their spread in animals given their epidemic 72 
and zoonotic potential. Conventional diagnostic methods that include in vitro isolation of the organism, 73 
immunohistochemistry and serology are time consuming have limited sensitivity and specificity (Sachse et 74 
al. 2009). 75 
We sought to improve, to accelerate and to simplify the diagnosis of C. psittaci and C. abortus infection by 76 
using real-time PCR, which is a fast, sensitive and specific diagnostic method, in particular for intracellular 77 
pathogens.  Despite their distinct host and tissue tropism, C. psittaci and C. abortus are phylogenetically so 78 
closely related that it is difficult to design a species-specific PCR targeting house-keeping genes, such as 79 
the 16S rRNA gene (Pannekoek et al. 2010; Lienard et al. 2011). Thus, the aim of this study was to develop 80 
a new real-time PCR-based method that could reliably detect and differentiate these two pathogens in 81 
clinical samples that could be used in routine diagnostic laboratories. 82 
We used a set of 120 samples, including bacterial reference strains, clinical specimens and DNA extracted 83 
from infected cell cultures to determine the performance of our PCR. The sensitivity and specificity of 84 
PCR1 for the detection of C. psittaci and C. abortus was 100%. When PCR1 is positive, PCR2 could 85 
discriminate C. psittaci from C. abortus with a positive predictive value of 100% and a negative predictive 86 
value of 88%. This new duplex PCR has been integrated into our automated molecular diagnostic platform 87 
in a prospective manner and identified two cases of human C. psittaci infection. This duplex PCR is a rapid 88 
and reliable method aimed to optimize the diagnosis of C. psittaci and C. abortus infections. 89 
Material and methods 90 
Real-time PCRs design  91 
Taking advantage of the increasing number of available sequenced genomes of the family Chlamydiaceae 92 
we designed a duplex real-time PCR to detect and to distinguish C. psittaci and C. abortus in clinical 93 
samples. The first real-time PCR (PCR1) targets a region of the 16S-23S rRNA operon. This PCR can detect 94 
both C. psittaci and C. abortus. The second real-time PCR (PCR2) targets a recently identified coding DNA 95 
sequence present only in C. psittaci (Voigt et al. 2012). All the primers and probes used for this study are 96 
presented in table 1. Primers and probes were designed using the Geneious 7.1.7 and Primer3Plus software. 97 
For PCR1, we performed an alignment of the 16S rRNA sequences available on GenBank and selected 98 
primers specific to C. psittaci and C. abortus (Table 1). For the real-time PCR2, specific to C. psittaci, we 99 
used the CDS CPSIT_0607 (GenBank Accession number NC_015470) predicted to encode for a protein of 100 
yet undetermined function, and absent from the genomes of all other Chlamydia, including C. abortus. 101 
Samples positive for both PCR1 and PCR2 were considered as positive for C. psittaci.  When PCR1 was 102 
positive and PCR2 was negative, genital samples or samples comprising abortion products were considered 103 
positive for C. abortus. Considering that some strains of C. psittaci may not have the CDS CPSIT_0607, 104 
respiratory samples positive for PCR1 and negative for PCR2 were considered positive for C. psittaci. 105 
DNA from bacterial strains or clinical samples were extracted according to manufacturer’s instructions with 106 
the LC automated system (Roche, Rotkreuz, Switzerland) and the MagNA Pure LC DNA isolation kit I 107 
(Roche) and resuspended into 100 µl of kit elution buffer.  108 
The real-time PCRs, were performed with the ABI Prism 7900 Sequence Detection system (Applied 109 
Biosystems, Rotkreuz, Switzerland). The reactions were achieved in a final volume of 20 µl with 5 µl of 110 
DNA sample for 45 cycles, using primers and probes at the concentrations indicated in table 1 and the 111 
TaqMan universal master Mix (Applied Biosystems). Cycling conditions were 2 min at 50°C, 10 min at 112 
95°C, followed by 45 cycles of 15 s at 95°C and 1 min at 60°C. Plasmids containing the target amplicons 113 
of the real-time PCR were obtained from RD-Biotech (Besançon, France). These plasmids were used as 114 
positive controls and to determine the sensitivity limits and the reproducibility of the PCRs. 115 
For each real-time PCR, a standard curve was generated by serial dilutions ranging from 5000 to 0.1 plasmid 116 
copies. This allowed the quantification of positive samples in copies per PCR reaction, i.e. in copies per 117 
five microliters of DNA. 118 
Sensitivity, specificity and reproducibility of the duplex PCR 119 
The analytic performances were assessed individually for each PCR using the corresponding positive 120 
control plasmids. The analytic sensitivity was performed with the positive control plasmids diluted from 50 121 
to 0.01 DNA copies per reaction. We also determined that the duplexing of the PCR did not affect the 122 
analytic sensitivity of the two PCRs. The intra- and inter-run reproducibility was assessed in duplicates in 123 
5 independent runs with dilutions of the plasmids corresponding to 5000, 2000, 1000, 500, 200, 100, 50, 124 
20, 10, 5, 2, 1, 0.5, 0.2 and 0.1 DNA copies per reactions.  125 
For all subsequent steps of the development, the PCRs were always tested as a duplex PCR. The sensitivity 126 
and specificity were tested using DNA from bacterial strains (Table 2), human (Table 4) and veterinary 127 
(Table 5) clinical samples, as well as DNA from Chlamydiales species (Table 3). 128 
Bacterial strains and samples 129 
To validate our new duplex PCR, we used a total of 120 samples which included 17 bacterial reference 130 
strains (15 ATCC and 2 clinical isolates) (Table 2), 49 samples DNA samples obtained from cell culture 131 
infected with C. psittaci (including all the 9 genotypes) and C. abortus and bacteria phylogenetically related 132 
to these two organisms (Table 3), 22 human clinical samples matching the tissue tropism of C. abortus and 133 
C. psittaci and 33 veterinary samples.  134 
Gold standard and discrepant results investigation 135 
For the investigation of discrepant results, we designed the primers CPSI_OMP_F4 and CPSI_OMP_R1 136 
for the amplification and the sequencing of the ompA gene of C. psittaci and C. abortus (Table 1). We also 137 
used the Chlamydiales-specific real-time PCR developed by Lienard and colleagues that target the 16S 138 
rRNA gene (Lienard, Croxatto et al. 2011). The PCR product of the Chlamydiales-specific real-time PCR 139 
could be further sequenced using the primers panCh16F2 and panCh16R2. The C. abortus specific real-140 
time PCR targeting the ompA gene was used to detect C. abortus (Pantchev et al. 2009). The binding region 141 
of the primer CPSI_00F, CPSI_00R and the probe CPSI_00P_MGB on the CDS CPSIT_0607 was 142 
amplified using the primers CPSI607-SEQ-F1 and CPSI0607-SEQ-R3. The elongation was performed 143 
using the primers CPSI_00F and the primer CPSI0607-SEQ-R3 (Table 1). 144 
Case studies  145 
To further validate the new duplex real-time PCR, we analysed a number of local cases. Each positive 146 
sample was analysed both with the Chlamydiales-specific real-time PCR as described by Lienard and 147 
colleagues (Lienard, Croxatto et al. 2011) and with the new duplex real-time PCR.  148 
Results 149 
Target gene, primers and probes 150 
Despite different host specificity and tissue tropism, C. psittaci and C. abortus are phylogenetically closely 151 
related bacteria. This prevents the differentiation of these two organisms by a single real-time PCR targeting 152 
a housekeeping gene. Thus, we decided to develop a duplex PCR consisting of (i) a PCR (PCR 1) targeting 153 
a house-keeping gene that allows the detection of both organisms but not their differentiation and (ii) a 154 
second PCR (PCR 2) targeting a gene that allows their specific differentiation. The first PCR targets the 155 
intergenic spacer of the 16S-23S rRNA operon (Table 1), while the second PCR targets the C. psittaci CDS 156 
CPSIT_0607. A comparative genomic study has shown that CPSIT_0607 is unique to C. psittaci (Voigt, 157 
Schofl et al. 2012).  158 
Analytical sensitivity and reproducibility of the two real-time PCRs 159 
The sensitivity of the two real-time PCRs was evaluated with 5 replicates of different plasmid control 160 
concentrations (50, 20, 10, 5, 2, 1, 0.5, 0.2, 0.1 copies per reaction). The PCR CP1 showed 100% detection 161 
for 10 or more DNA copies per reaction, 90% for 5 and 2 copies per reactions and 60% for 1 copy per 162 
reaction (Fig. 1A). The PCR 2 showed 100% detection for 5 or more DNA copies per reaction, 80% for 2 163 
copies per reactions and 50% for 1 copy per reaction (Fig. 1B). The intra- and inter-run reproducibility of 164 
PCR1 and PCR2 were assessed on 5 independent runs in duplicates using serial dilutions of the positive 165 
control plasmid ranging from 5000 to 0.1 DNA copies per ml (Fig. 2). When plotting the cycle threshold 166 
(Ct) of duplicates of the same amplification, we calculated a R2 of 0.96 for PCR1 and 0.97 for PCR2, which 167 
is excellent (Fig. 2A and 2B). To test the inter-run reproducibility we plotted the 10-copy and 100-copy 168 
positive control of 10 successive runs, which revealed that only one 10-copy positive control exhibited a 169 
Ct value that was above two standard deviation of the mean (Fig. 2C).  170 
Performance of the duplex real-time PCR 171 
The overall performance of the duplex PCR was assessed with a total of 120 samples. No amplification was 172 
observed with 17 bacterial strains (15 ATCC and 2 clinical isolates), including bacteria sharing the same 173 
tissue tropism as C. psittaci or C. abortus (Table 2).  174 
Forty-nine samples used to test the specificity of the PCRs were  DNA samples (obtained from infected cell 175 
culture material) from bacteria phylogenetically related to C. psittaci and C. abortus, namely C. pecorum 176 
and C. pneumoniae, Waddlia chondrophila, Estrella lausannensis, Criblamydia sequanensis, 177 
Protochlamydia naegleriophila strain Knic and Simkania negevensis (Table 3). The results of the duplex 178 
PCR were correct for 42 of the 49 samples, with 8 results being discordant. Six of them correspond to DNA 179 
samples obtained from cell cultures infected with C. psittaci genotype E/B, C and M56 that were found 180 
positive for the PCR1 and negative for the PCR2 targeting the CDS CPSIT_0607. The analysis of the 181 
genome of C. psittaci E/B revealed that this strain is devoid of the homolog of the CDS CPSI0607 (Van 182 
Lent, Piet et al. 2012). The two other discordant results corresponded to samples thought to contain C. 183 
pecorum DNA. These samples were positive for PCR1 and negative for PCR2 with our duplex PCR and 184 
thus interpreted as positive for C. abortus. These two samples were further analysed both with the 185 
Chlamydiales-specific PCR targeting the 16S rRNA sequence (Lienard, Croxatto et al. 2011) and a C. 186 
abortus specific PCR targeting the ompA gene (Pantchev, Sting et al. 2009). Both PCRs were positive for 187 
C. abortus, thereby confirming the presence of C. abortus DNA and validating our new duplex PCR. 188 
The samples tested with the duplex PCR also included 22 human clinical samples, which selection was 189 
biased towards genital and respiratory tract samples, matching the tissue tropism of C. abortus and C. 190 
psittaci respectively. One sample was a uterus and urethral smear that was positive for C. abortus 191 
corresponding to case 1 described above. The other samples were all negative for C. psittaci and C. abortus. 192 
We obtained 100% concordance between our duplex PCR and the indicated gold-standard (Table 4). We 193 
next tested the duplex PCR on 33 veterinary samples. The sample corresponding to a bird spleen positive 194 
for C. psittaci (case 2 discussed above) was also identified as C. psittaci with our new duplex PCR. The 27 195 
ovine placental samples positive for C. abortus (Longbottom et al. 2013), were all correctly identified by 196 
our duplex PCR. No amplification was obtained with sample 1088D that was negative for both C. abortus 197 
and C. psittaci according to our collaborator gold standard (Longbottom, Livingstone et al. 2013). In 198 
contrast we obtained amplification with the PCR CP16 but not with the PCR 2 revealing the presence of C. 199 
abortus DNA in samples 1086D, 1092D, 723P, 572P. These samples were found positive for C. abortus 200 
with the Pan-Chlamydiales PCR and the C. abortus specific PCR targeting the ompA gene (Pantchev, Sting 201 
et al. 2009) (Table 5). 202 
On the basis of these 114 samples we determined 100% sensitivity and 100% specificity for our new C. 203 
psittaci and C. abortus duplex PCR (Table 6A). Moreover, when PCR1 was positive, PCR2 could 204 
differentiate C. psittaci from C. abortus with a positive predictive value of 100% and a negative predictive 205 
value of 91% (Table 6B).  206 
Case study 207 
The new duplex PCR was introduced into our diagnostic laboratory for a retrospective and prospective case 208 
study analysis. Using our new duplex real-time PCR, we could confirm one case of ornithosis (Senn & 209 
Greub 2008) and one case of C. abortus infection. We could also diagnose 2 cases of psittacosis. All these 210 
cases are summarized in table 7 and in supplementary table 1.   211 
Optimisation of PCR1  212 
The CDS CPSI_0607 was chosen as the target for PCR2 on the basis of a comparison of the genome of C. 213 
psittaci 6BC with the genomes of other Chlamydiacae species (Voigt, Schofl et al. 2012). Our in silico 214 
analysis first identified 5 homologs of CPSIT_0607 in C. psittaci C19/98, C. psittaci 01DC11, C. psittaci 215 
02DC15, C. psittaci 08DC60 (Schofl et al. 2011) and C. psittaci RD1 (Seth-Smith et al. 2011). The specific 216 
primers and the probe for real-time PCR2 were designed using an alignment of these six sequences. 217 
However, the sequencing of the target of the PCR 2 revealed a polymorphism (C147G) in the binding region 218 
of the reverse primer in some C. psittaci positive samples. This mutation is predicted to induce a 5.8°C 219 
decrease in the melting temperature (Tm) of the oligonuceotide CPSI_00R, but the cycle threshold (Ct) of 220 
PCR1 and of PCR2 are similar in C. psittaci positive samples with the mutation C147G (see suppl. Table 221 
S2). Thus, the mutation C147G does not impact the sensitivity of our duplex PCR. Nevertheless, we decided 222 
to update our real-time PCR by using a combination of 2 reverse primers, namely the primer 223 
CPSI_00R_147C and CPSI_00R_147G. We tested the duplex PCR containing this new primer on 5 C. 224 
psittaci DNA samples containing the C147G mutation. The PCR containing the reverse primer 225 
CPSI_00R_147C/G was as efficient at amplifying the target C. psittaci sequence as the PCR containing the 226 
original primer CPSI_00R (Suppl. table 2). 227 
Discussion 228 
We have developed a new duplex real-time PCR which strength is to rapidly detect and distinguish C. 229 
psittaci and C. abortus in clinical samples.  The first PCR, which is based on the 16S rRNA gene, is able 230 
to identify C. psittaci and C. abortus with 100% of sensitivity and specificity with a sensitivity limit lower 231 
than 10 DNA copies per reaction. This PCR is suitable for the screening of C. psittaci and C. abortus 232 
because of the 100% sensitivity for the two species. The second PCR that targets the CDS CPSI0607 found 233 
in the genome of C. psittaci isolate 6BC and absent from all known C. abortus genomes allows 234 
differentiating these two pathogens. The specific PCRs published to date for the detection of C. psittaci and 235 
C. abortus target highly polymorphic genes, such as the ompA gene encoding the major outer membrane 236 
protein (Pantchev, Sting et al. 2009). So far, none of the published C. psittaci/C. abortus real-time PCR 237 
fulfilled the characteristic for an implementation in our molecular diagnosis platform based on the Taqman 238 
technology and using standardized PCR in term of length of the amplicon and melting temperature of the 239 
primers and probes and elongation temperature. This standardisation allows us to run all the real-time PCR 240 
in batches in 384 multi-well plates. Branley et al have developed a PCR targeting the 16S rRNA gene but 241 
using the SYBR-green technology and that presented a melting temperature lower than the target melting 242 
temperature of our platform (60°C) {Branley, 2008 #631}. Most of the species specific real-time PCR target 243 
outer membrane proteins with a high risk of loth of sensitivity due to single nucleotide polymorphism 244 
{Creelan, 2000 #629}{Heddema, 2006 #301}{Heddema, 2015 #632}{Pantchev, 2009 #286}. The incA 245 
gene encoding for the inclusion membrane protein A have been used to design a C. psittaci specific PCR 246 
but published primers did not reach the Tm of our plateform {Menard, 2006 #25}. We recently developed 247 
a Pan-Chlamydiales real-time PCR targeting the 16S rRNA able to detect with a high sensitivity (5 DNA 248 
copies per reaction) and high specificity the presence of Chlamydiales species in clinical or environmental 249 
samples. Nevertheless, when positive, a further sequencing of the PCR amplicons is required to identify the 250 
bacteria at the species level (Lienard, Croxatto et al. 2011). Our new duplex PCR is a straightforward 251 
method to rapidly detect and distinguish C. psittaci and C. abortus on molecular diagnosis platform using 252 
the Taqman technology. 253 
During the validation of our new duplex PCR, we found that the available genomes of C. psittaci genotype 254 
A, B, D, E, F and WC contain orthologs of the CPSI0607 {Van Lent, 2012 #57}. In contrast the available 255 
genomes of C. psittaci genotype E/B, identified in ducks, cattle and muskrats, genotype C, isolated from 256 
ducks and geese and genotype M56, isolated in muskrats are devoid of this CDS (Geens et al. 2005; Van 257 
Lent, Piet et al. 2012). The positive predictive value for the identification of C. psittaci is 100%, while the 258 
negative predictive value is 88%. The analysis of more C. psittaci genomes will precise the distribution of 259 
this gene. Thus, samples positive for both PCR1 and PCR2 can accurately be identified as containing C. 260 
psittaci DNA.  Conversely, genital samples or samples consisting of abortion products positive for PCR1 261 
and negative for PCR2 were presumably identified as C. abortus. Respiratory samples positive for PCR1 262 
and negative for PCR2 were considered as putatively positive for C. psittaci, especially in the context of 263 
bird exposure. 264 
During the validation of our new diagnosis methods, we also performed an in silico survey of the new 265 
Chlamydiacae DNA sequences submitted together with the sequencing of the target gene of the PCR2 of 266 
our duplex PCR. This allowed us to identify a polymorphism that could affect the binding of the reverse 267 
primer of this PCR. This led us to design a degenerate primer to prevent any decrease in PCR sensitivity. 268 
Our development is an example of the importance of a continuous in silico and in vitro survey of the 269 
reliability of PCR-based molecular diagnosis methods to overcome the appearance of new pathogen 270 
variants that could be missed. This is particularly true for pathogens for which the number of available 271 
sequences is limited (i.e. emerging pathogens), or for pathogens with a high rate of mutations, such as 272 
viruses. 273 
The zoonotic incidence of C. psittaci and C. abortus is well documented but their incidence in human 274 
diseases might be underestimated (Braukmann et al. 2012; Geigenfeind, Vanrompay et al. 2012).  In 275 
particular, about 50% of pneumonia cases remain diagnosed as of unknown etiology. C. psittaci should 276 
especially be considered in the differential diagnosis if history reveals an exposure to birds. The situation 277 
is similar for abortions, where nearly 50% of cases are of unexplained etiology (Baud et al. 2008) and could 278 
sometimes be caused by C. abortus, particularly in rural areas or following exposure to sheep at lambing. 279 
The sensitivity and the specificity of our new duplex PCR make it a powerful tool to confirm or to exclude 280 
suspected C. psittaci or C. abortus infections during routine diagnosis. Moreover, the high throughput 281 
potential together with the short turnaround time and the low cost of this real-time PCR make it a powerful 282 
tool for large-scale screening programs during outbreaks, if such situations arise. This may be very 283 
important, since the high infectivity of C. psittaci by the airway confers a significant outbreak potential 284 
(Heddema et al. 2006; Gaede et al. 2008; Belchior et al. 2011; McGuigan et al. 2012) and consideration as 285 
a potential bioterrorism agent.   286 
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Table 1. Oligonucleotides sequences 371 
Oligonucleotide  Target gene Sequence (5'-3') Modification/ 
fluorochrome 
TM (°C) Final 
concentration 
(µM) 
Amplicon 
length (bp) 
Specificity References 
Real time PCR 
        
CPSI_F 16S-23S operon AAGGAGAGAGGCGCCCAA   59.7 0.35   C. psittaci and C. abortus  This study  
CPSI_R_LNA 16S-23S operon CAA{C}CTAGTCAAACCGTCCTAA LNA  {}  60 0.35 133 C. psittaci and C. abortus  This study  
CPSI_P_MGB 16S-23S operon  ACTGGGATGAAGTCGTAAC FAM, DQ 66.6 0.2   C. psittaci and C. abortus  This study 
CPSI_00F CDS CPSI0607 AGCATTAGCCAGCGCTTTAGA   58.1 0.35 118 C. psittaci  This study 
CPSI_00R CDS CPSI0607 TCTCTGAGCAAAAACACTGCGT   58.8 0.35 118 C. psittaci  This study  
CPSI_00R_C147G CDS CPSI0607 TCTCTCAGCAAAAACACTGCGT 
 
53  0.35 118 C. psittaci  This study  
CPSI_00P_MGB CDS CPSI0607 ACAAAGACCTGGCGAGTA VIC, DQ 67 0.2   C. psittaci  This study 
panCh16F2 (a) 16S rRNA CCGCCAACACTGGGACT   60 0.1   Chlamydiales 
(Lienard, Croxatto et 
al. 2011) 
panCh16R2 (a) 16S rRNA GGAGTTAGCCGGTGCTTCTTTAC   60 0.1 207 to 215 Chlamydiales 
(Lienard, Croxatto et 
al. 2011) 
panCh16S 16S rRNA CTACGGGAGGCTGCAGTCGAGAATC FAM, BHQ 60 0.1   Chlamydiales 
(Lienard, Croxatto et 
al. 2011) 
CpaOMP1-F ompA GCAACTGACACTAAGTCGGCTACA   57.4 0.9   C. abortus 
(Pantchev, Sting et al. 
2009) 
CpaOMP1-R ompA ACAAGCATGTTCAATCGATAAGAGA   52.8 0.9   C. abortus 
(Pantchev, Sting et al. 
2009) 
CpaOMP1-Sb ompA 
TAAATACCACGAATGGCAAGTTGGTTTAGC
G 
FAM, 
TAMRA 60 0.2 82 C. abortus  
(Pantchev, Sting et al. 
2009) 
PCR and 
sequencing                  
CPSI_OMP_F4 ompA GATCCTTGCGATCCTTGC   55.3     C. psittaci and C. abortus  This study 
CPSI_OMP_R1 ompA TGATAGCGGGACAAAAAGTTAGGA   60     C. psittaci and C. abortus  This study 
CPSI607_SEQ_F1 CDS CPSI0607 ATGATTAACACAGCTATCGGC   56.6     C. psittaci  This study 
CPSI607_SEQ_R3 CDS CPSI0607 ACTTGTTCCGCAGTTTGTTCCATC   62.3   393 C. psittaci  This study 
        
 LNA = Locked nucleic acid, MGB = Minor groove binder, FAM = 6-carboxy-fluorescein, VIC = TaqMan VIC reporter dye, DQ = Dark quencher, 372 
BHQ = Black hole quencher, (a) also used for PCR and sequencing. 373 
  374 
Table 2. Bacterial  species used to test the specificity 
   
 Species Source or strains 
 Escherichia coli ATCC 25912 
 Klebsiella pneumoniae ATCC  BAA1706 
 Serratia marcescens  ATCC 8100 
 Pseudomonas aeruginosa  ATCC 27853 
 Haemophilus influenzae ATCC 49247 
 Haemophilus paraphrophilus ATCC  49917 
 Staphylococcus aureus ATCC 29213 
 Staphylococcus epidermidis ATCC 14990 
 Streptococcus pneumoniae ATCC 49619 
 Streptococcus pyogenes  ATCC 19615 
 Streptococcus agalactiae ATCC 12386 
 Streptococcus mitis  ATCC 6249 
 Enterococcus faecalis  ATCC 29212 
 Clostridium sporogenes  ATCC 19404  
 Lactobacillus spp. (1)  Clinical specimen 
 Bifidobacterium longum (1)  Clinical specimen  
 Candida albicans  ATCC 90028 
   
 (1) Identification using MALDI-TOF  
   
   
 375 
  376 
Table 3. Bacterial DNA used to validate the duplex PCR 377 
  Organism C. psittaci/C. abortus duplex PCR result  
Chlamydiales 
 
    
 Chlamydia psittaci 10298  
Chlamydia psittaci
  Chlamydia psittaci  10525  
Chlamydia psittaci
  Chlamydia psittaci 10/282 
Chlamydia psittaci
  Chlamydia psittaci 10/423 
Chlamydia psittaci
  Chlamydia psittaci 90/1051 
Chlamydia psittaci
  Chlamydia psittaci 89/1291 
Chlamydia psittaci
  Chlamydia psittaci 91/0154 
Chlamydia psittaci
  Chlamydia psittaci 99_3005 
Chlamydia psittaci
  Chlamydia psittaci 06/020 
Chlamydia psittaci
  Chlamydia psittaci 06/052 
Chlamydia psittaci
  Chlamydia psittaci 2000/332 
Chlamydia psittaci
  Chlamydia psittaci 91/0237 
Chlamydia psittaci
  Chlamydia psittaci 96_3218 
Chlamydia psittaci
  Chlamydia psittaci 98_6098 
Chlamydia psittaci
  Chlamydia psittaci 18_290800 
Chlamydia psittaci
  Chlamydia psittaci 96_1867_30 
Chlamydia psittaci
  Chlamydia psittaci 3_20901 (a)  
Chlamydia abortus
  Chlamydia psittaci 4_20901 (a)  
Chlamydia abortus
  Chlamydia psittaci 5_20901 (a)  
Chlamydia abortus
  Chlamydia psittaci 2/290300  (a)  
Chlamydia abortus
  Chlamydia abortus S263  
Chlamydia abortus
  Chlamydia abortus 094_POS  , Greek ‘variant strain’, ovine  
Chlamydia abortus
  Chlamydia abortus 095_A22, ovine placenta 
Chlamydia abortus
  Chlamydia abortus 096_S82/3, ovine placenta 
Chlamydia abortus
  Chlamydia abortus 097_09/04, ovine placenta 
Chlamydia abortus
  Chlamydia abortus 097_09/02, ovine placenta 
Chlamydia abortus
  Chlamydia abortus 099_11/01, ovine placenta 
Chlamydia abortus
  Chlamydia abortus 100_S135, ovine placenta 
Chlamydia abortus
  Chlamydia abortus 101_S26/3, Moredun reference strain (sequenced), ovine placenta 
Chlamydia abortus
  Chlamydia abortus 102_91/7, ovine placenta 
Chlamydia abortus 
  Chlamydia pecorum 093_P787, arthritogenic strain, ovine synovial fluid  
Chlamydia abortus (b) 
  Chlamydia pecorum 103_84/521F – ovine faecal strain  
Chlamydia abortus (b) 
  Chlamydia pecorum LW623 
negative
  Chlamydia pecorum 66P130 
negative
  Chlamydia pecorum 710S 
negative
  Chlamydia pecorum L71 
negative
  C.pneumoniae VR1310  
negative
    
Parachlamydiales   
 Waddlia chondrophila  
negative
  Parachlamydia acanthamoebae  
negative
  Estrella lausannensis  
negative
  Criblamydia sequanensis  
negative
  Protochlamydia naegleriophila strain Knic  
negative 
  Simkania negevensis  
negative 
       
(a) C. psittaci genotype E/B (Van Lent, Piet et al. 2012) 378 
(b) The presence of C. abortus DNA was confirmed by the pan-Chlamydiales PCR followed by sequencing (Lienard, Croxatto et 379 
al. 2011) and by the real-time PCR C. abortus specific (Pantchev, Sting et al. 2009).  380 
Table 4. Clinical specimen used to validate the duplex PCR  381 
Sample type Gold standard identification 
C. psittaci/C. abortus 
duplex PCR result  
      
Uterus and urethral smear  Chlamydia abortus (a) Chlamydia abortus 
Urethral swab  Chlamydia trachomatis  negative 
Mouth swab (3 samples) Oropharyngeal comensal flora  negative 
Nasopharyngeal secretions (2 samples) Chlamydia pneumoniae  negative 
Nasopharyngeal secretions (2 samples) Mycoplasma pneumoniae (b) negative 
Bronchoalveolar lavage (2 samples) Legionella pneumophila (b) negative 
Nasal swab  Bordetella pertussis negative 
Nasopharyngeal secretions (2 samples) Bordetella pertussis  negative 
Expectoration Mycobacterium tuberculosis  negative 
Bronchoaspiration  Mycobacterium tuberculosis  negative 
Bronchoaspiration  Aspergillus fumigatus negative 
Bronchoalveolar lavage Aspergillus fumigatus negative 
Bronchoalveolar lavage Pneumocystis jirovecii negative 
Bronchoaspiration Pneumocystis jirovecii  negative 
Drain fluid from aortic valve Coxiella burnetti  negative 
Prosthetic fragment Coxiella burnetti  negative 
      
(a) = pan-Chlamydiales PCR followed by sequencing (Lienard, Croxatto et al. 2011) 382 
(b) = M. pneumoniae, L. pneumophila duplex real-time PCR (Welti et al. 2003) 383 
  384 
 385 
Table 5. Veterinary specimens used for validation of the duplex PCR  386 
Sample type Gold standard identification C. psittaci/C. abortus duplex PCR result  
   
Bird spleen Chlamydia psittaci (a) Chlamydia psittaci 
Fragment  of sheep placenta Chlamydia abortus (a) Chlamydia abortus  
Fragment  of sheep placenta Chlamydia abortus (a) Chlamydia abortus  
Biopsy 307A, placental cotyledonary Chlamydia abortus  Chlamydia abortus 
Biopsy 439P, placental cotyledonary  Chlamydia abortus  Chlamydia abortus 
Biopsy 452A, placental cotyledonary  Chlamydia abortus  Chlamydia abortus 
Biopsy 511P, placental cotyledonary  Chlamydia abortus  Chlamydia abortus 
Biopsy 512P, placental cotyledonary Chlamydia abortus  Chlamydia abortus 
Biopsy 545A, placental cotyledonary Chlamydia abortus  Chlamydia abortus 
Biopsy 745P, placental cotyledonary Chlamydia abortus  Chlamydia abortus 
Biopsy 1725N, placental cotyledonary Chlamydia abortus  Chlamydia abortus 
Biopsy 2571N, placental cotyledonary Chlamydia abortus  Chlamydia abortus 
Biopsy 451P, placental cotyledonary Chlamydia abortus  Chlamydia abortus 
Biopsy 828P, placental cotyledonary Chlamydia abortus  Chlamydia abortus 
Biopsy 851P, placental cotyledonary Chlamydia abortus  Chlamydia abortus 
Biopsy 1504N, placental cotyledonary Chlamydia abortus  Chlamydia abortus 
Biopsy 1535N, placental cotyledonary Chlamydia abortus  Chlamydia abortus 
Biopsy 1683N, placental cotyledonary Chlamydia abortus  Chlamydia abortus 
Biopsy 2542N, placental cotyledonary Chlamydia abortus  Chlamydia abortus 
Biopsy 254B, placental cotyledonary Chlamydia abortus  Chlamydia abortus 
Biopsy 314A, placental cotyledonary Chlamydia abortus  Chlamydia abortus 
Biopsy 717A, placental cotyledonary Chlamydia abortus  Chlamydia abortus 
Biopsy 1019P, placental cotyledonary Chlamydia abortus  Chlamydia abortus 
Biopsy 1568N, placental cotyledonary Chlamydia abortus  Chlamydia abortus 
Biopsy 2537N, placental cotyledonary Chlamydia abortus  Chlamydia abortus 
Biopsy 637P, placental cotyledonary Chlamydia abortus  Chlamydia abortus 
Biopsy 758A, placental cotyledonary Chlamydia abortus  Chlamydia abortus 
Biopsy 1509N, placental cotyledonary Chlamydia abortus  Chlamydia abortus 
Biopsy 1088D, placental cotyledonary negative negative 
Biopsy 1086D, placental cotyledonary negative Chlamydia abortus*  
Biopsy 1092D, placental cotyledonary negative Chlamydia abortus*  
Biopsy 723P, placental cotyledonary negative Chlamydia abortus**  
Biopsy 572P, placental cotyledonary negative Chlamydia abortus**  
      
(a) = pan-Chlamydiales PCR followed by sequencing (Lienard, Croxatto et al. 2011). 387 
*C. abortus DNA also detected with the Pan-Chlam, and with the C. abortus specific RT-PCR ompA. 388 
**infected animal, C. abortus DNA also detected with the Pan-Chlam, and with the C. abortus specific RT-PCR ompA.  389 
Table 6. Performance of the duplex PCR. The duplex PCR was tested on 114 samples. The performance of 390 
PCR1 that can detect C. psittaci and C. abortus was calculated on the 114. The performance of PCR2 391 
specific of C. psittaci was calculated on the 61 positive for PCR1. 392 
393 
 394 
  395 
Table 7. Case study  396 
   Sample  
Interpretation 
of the duplex 
PCR C. 
psittaci/C. 
abortus  
PCR1 result  PCR2 result  Clinical features  
Case 1: C. abortus 
infection of a pregnant 
woman 2012 (a) 
Uterus and urethral smear 
from a pregnant woman  
C. abortus  Positive  Negative  
Pregnant woman in contact 
with a flock of sheep  
Fragment  of  sheep 
placenta from an abortive 
sheep  
C. abortus  Positive Negative Abortion 
Fragment  of  sheep 
placenta from a second 
abortive sheep  
C. abortus  Positive Negative Abortion  
Case 2: Parrot from a 
public park (b) 
Parrot spleen  C. psittaci  Positive  Positive  
Dead parrot from a public park 
dissected by an employee of a 
veterinary clinic that 
subsequently developed 
psittacosis  
Case  3: Pigeon owner 
2013 (a)  
Expectoration from the 
pigeon owner  
C. psittaci Positive  Positive 
Fever and hemoptysis. 
Radiologic condensations of 
the basoposterior segment of 
the right lower lobe of the lung 
in a patient in contact with a 
pigeon loft 
Pigeon choanal and cloacal 
swab  
C. psittaci Positive Positive Dead  
Dust from the pigeon loft  C. psittaci  Positive  Positive  -  
 Case 4: Worker on the 
roof of a building (a)  
Endotracheal secretions  C. psittaci  Positive  Positive  
Respiratory illness in a patient 
working on the roof of building   
(a) This study  397 
(b) (Senn & Greub 2008) 398 
  399 
Figure legends 400 
Figure 1. Analytic sensitivity of the two real-time PCRs. The analytic sensitivity was evaluated with 5 401 
replicates of different plasmid control concentrations (50, 20, 10, 5, 2, 1, 0.5, 0.2, 0.1 copies per reaction) 402 
for PCR1 (A) and PCR2 (B).  403 
Figure 2. Reproducibility of the two real-time PCR. (A and B) Intra-run variability of the real-time PCR1 404 
(A) and PCR2 (B) between duplicates of the control plasmid. (C and D) Inter-run variability using 10 and 405 
100 plasmid copies, as obtained during 10 successive runs for PCR1 (A) and PCR2 (B); the solid black 406 
lines show the mean cycle threshold (Ct) values and the dashed lines each side of the means indicates two 407 
standard deviations. 408 
